It slows down stomach emptying, reduces hunger signals, and helps regulate blood sugar levels
The combination of BC and dapagliflozin in the treatment of DKD can enhance the therapeutic effect, reduce renal injury, and delay the progression of the disease (70)
As of August 2026, Retatrutide (LY3437943), Eli Lillys investigational triple-hormone receptor agonist targeting GLP-1, GIP, and glucagon pathways, remains unapproved because the company has not yet submitted its Biologics License Application
But GLP-1 drugs are pricey, and nearly two-thirds of states said cost is a hurdle to approving coverage of the medications through Medicaid
Yeung CK, Chan HH
The most effective of the three at appetite suppression